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Abstract
Background: Primary care practices provide a gate-keeping function in many health care systems. Since depressive
disorders are highly prevalent in primary care settings, reliable detection and diagnoses are a first step to enhance
depression care for patients. Provider training is a self-evident approach to enhance detection, diagnoses and
treatment options and might even lead to improved patient outcomes.
Methods: A systematic literature search was conducted reviewing research studies providing training of general
practitioners, published from 1999 until May 2011, available on the electronic databases Medline, Web of Science,
PsycINFO and the Cochrane Library as well as national guidelines and health technology assessments (HTA).
Results: 108 articles were fully assessed and 11 articles met the inclusion criteria and were included. Training of
providers alone (even in a specific interventional method) did not result in improved patient outcomes. The
additional implementation of guidelines and the use of more complex interventions in primary care yield a
significant reduction in depressive symptomatology. The number of studies examining sole provider training is
limited, and studies include different patient samples (new on-set cases vs. chronically depressed patients), which
reduce comparability.
Conclusions: This is the first overview of randomized controlled trials introducing GP training for depression care.
Provider training by itself does not seem to improve depression care; however, if combined with additional
guidelines implementation, results are promising for new-onset depression patient samples. Additional
organizational structure changes in form of collaborative care models are more likely to show effects on
depression care.
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Background
Depressive disorders are highly prevalent in the general
public. The 12-month prevalence of Major Depression
among Europeans has shown to be approximately 6.9%
w h i l ec o n s e r v a t i v ee s t i m a t e so ft h el i f e t i m ep r e v a l e n c e
range up to 14% [1,2]. Depression is associated with sig-
nificant functional impairment and reduced quality of
life [3,4], excess mortality rates [5] and particularly high
costs for society and health care systems [6-9]. Consid-
ering the large effects of the disease on individuals and
society, it seems clear that early detection and treatment
is a desirable goal in order to promote remission and
reduce negative consequences [10].
While 50 to 70 per cent of all depressed patients con-
sult their primary care physician during an episode,
therefore making them the profession most likely to be
seen [11,12], depression in primary care remains under-
recognised and under-treated [13]. As Bijl and collea-
gues (2004) summarise, the elements of detection, diag-
nosis and treatment determine successful depression
management in health care. Previous trials showed that
approximately 50 per cent of all depressed patients in
primary care were not diagnosed as such [14-16]. This
is a major downfall in depression care, since even
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nificant [17]. Obviously part of this is due to reluctance
to seek treatment among patients themselves, resulting
from concerns on effectiveness of treatment and per-
ceived absence of treatment necessity [18].
To objectify diagnoses, the use of screening instru-
ments has been promoted by the U.S. Preventive Ser-
vices Task Force, when adequate treatment and care
possibilities are available [19]. Reviews showed that
screening alone does not improve depression outcomes
for patients [20], but needs further organizational
changes [21]. These structural interventions, including
collaborative care approaches as well as provider train-
ing, represent an attempt to increase detection and diag-
nosis of depressed patients and therefore promote
enhanced treatment. Several treatment options that sup-
port primary care physicians in treatment and that are
also directly delivered by general practitioners (such as
PST- problem solving therapy) have been found to be
effective for depression [22,23].
Primary care practices play a central role in many
health care systems- this kind of gate-keeping is even
associated with improved coordination and outcomes
[24]. This circumstance makes general practitioners
ideal as a base for first steps in treatment, also referred
to as a “stepped care” approach [25]. “Watchful waiting”
and low intense interventions such as self-help
approaches have to be encouraged as useful strategies
[26]. In order to make full use of this opportunity,
improvement of detection rates and diagnosis is inevita-
ble. Improving skills of primary care providers can be
achieved by different strategies. Consultation-liaison
involves a persistent educational supervision of the gen-
eral practitioner by a mental health specialist. This
approach has not been shown to be effective in reducing
depressive symptoms [27]. As indicated by Cape et al.
(2010), another point of intervention can be to train pri-
mary care providers in diagnosis and treatment strate-
gies without the inclusion of mental health specialists
(such as collaborative care), considering limited financial
resources of health care systems [27]. Moderated by
higher detection rates and better knowledge on treat-
ment options, improvement on this level could subse-
quently lead to higher remission rates in less time and
improved depression outcomes.
In the past, these programmes of provider education
have been evaluated, yielding unclear results on effec-
tiveness of the intervention regarding health gain out-
comes [21]. This study therefore reviews current
literature for an updated overview. It is the first over-
view of randomized controlled trials that exclusively
investigates interventions that apply practitioner
training.
Methods
Literature Search
This review was prepared according to the systematic
literature review guidelines of the Centre for Reviews
and Dissemination [28] and follows PRISMA (Preferred
Reporting Items for Systematic reviews and Meta-Ana-
lyses) suggestions [29]. A systematic literature search
was conducted reviewing research studies, published
from 1999 until May 2011, available on the electronic
databases Medline, Web of Science, PsycINFO and the
Cochrane Library as well as national guidelines and
health technology assessments (HTA). In addition, the
bibliographies of the selected articles were searched.
Grey literature was not searched. 1999 as a starting
point of the search was chosen to include at least the
last 10 years of publications. The latest review on this
topic, including studies from 1999 onward, was con-
ducted in 2003, and we meant to include those studies
as well [21]. The aim was to evaluate if newer, more
recent studies would show clearer effects of the inter-
vention than previous overviews.
The terms (depression OR depressive disorder) AND
(general practitioner OR general practice OR primary
care OR family practice) AND (training OR education)
served as search criteria within titles and abstracts. All
terms were also used as MeSH terms where applicable.
Test searches were run preceding the actual search in
order to determine the right search terms. Additional
File 1 shows the Medline search strategy in detail. The
search was limited to English and German language
publications.
Inclusion criteria
Abstracts were screened by two authors using the fol-
lowing inclusion criteria: (i) randomized controlled trials
(RCT) or review articles (ii) of the adult (≥ 18 years)
general population, (iii) evaluating interventional pro-
grammes including general practitioner training, men-
tioned in the abstract and (iv) reporting effects on
depressive symptomatology. All extracted review articles
were scanned and hand-searched for further relevant
publications from 1999 onward.
Studies examining effects in specific study samples
(such as diabetic patients with co-morbid depression)
were excluded. Research of those specific samples was
thought to provide only limited evidence for primary
health care patients in general. All articles where a clear
decision could not be made based on title or abstract
were retrieved for a more detailed analysis. In case of
disagreement, a third reviewer was consulted and then a
consensus decision was achieved.
Training and education of general practitioners was
defined as a professional intervention [21] that involves
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focus on optimising diagnosis as well as treatment. Stu-
dies involving additional organisational interventions
were excluded. Additional file 2 gives an overview on
excluded studies.
Data extraction
Primarily, methodical data on sampling, study design,
intervention procedure, and outcome criteria were
extracted from all selected studies. Extraction of results
focussed on assessing symptom alteration primarily.
Only data related to a change in symptom severity
(scale scores, remission rates) were extracted. Effect
sizes were only calculated for the outcomes considered
as relevant (symptom change). Secondly, the selection
criteria described in the above section were then reap-
plied to ensure accurate study inclusion.
Study Quality
Study quality was also assessed by two independent
raters using a modified scale based on work by Mon-
crieff and colleagues [30]. The scale was modified by
leaving out irrelevant items such as medication side-
effects. It consists of 21 items leading to a maximum
score of 42 points (Table 1). Each item, if not specified
otherwise, was scored as 2 (fully met the quality criter-
ion), 1 (partially met the quality criterion) or as 0 (did
not meet the quality criterion). After a first independent
run-through of ratings, the two raters met with a third
independent researcher in order to discuss disagree-
ments in scoring until a consensus was reached. Study
protocols were consulted where possible.
Effect Size and meta-analysis
Whenever applicable, standardized mean effect sizes
(Cohen’s d) were calculated from the data reported. At
times, studies only reported scores that could not be
used in effect size calculation and efforts to retrieve data
directly from the authors were made. Data was entered
to interpret negative standardized means in favour of
the intervention. Results of cluster trials were used
when the authors accounted for the effect of cluster ran-
domization properly. According to Cohen (1988), effect
sizes of 0.2 are considered small, while d = 0.5 repre-
sents a moderate effect and d = 0.8 is regarded a large
effect [31]. A meta-analysis was conducted using Review
Manager Software [32]. Due to the diversity of GP train-
ing in the studies, standardized mean effects were
pooled - firstly, for studies with GP training only, sec-
ondly, for studies introducing additional guidelines and
lastly for studies including more complex interventions.
Subgroup analysis (patient inclusion, age of patients)
were not carried out due to the unavailability of suffi-
cient data. Analysis of the heterogeneity of prevalence
across studies was done through I
2 statistic and Cochran
Q. A fixed effect model was applied since heterogeneity
was low.
Results
Search results
The results of the systematic literature search are shown
in Figure 1. Interrater reliability showed substantial
agreement (Kappa = 0.74). Overall, 108 potentially rele-
vant articles were identified. After retrieving all full arti-
cles, 97 further articles were rejected as not fulfilling the
selection criteria. Eleven articles were assessed and
included for detailed analysis. Relevant study character-
istics can be found in Table 2. Three articles are double
publications of the same studies and will be subtracted
for the following overview. The QuEST intervention is
described in detail in a publication by Rost et al. (2000).
Therefore, this reference will be used when referring to
that study.
Study characteristics
All, but one, studies were conducted in anglophone
countries, among them Great Britain (n = 4) and one
study each in Canada, the United States and Australia.
The sample sizes varied from 145 [33] to 733 [34,35].
Three studies included patients with a categorical (e.g.
diagnostic system based) diagnosis of depression
[33,36,37], while the other five made use of symptom
rating scales (self-report scales). Gask et al. (2004) and
Worrall et al. (1999) both based their samples on refer-
rals by the general practitioner (having the GP deter-
mine whether the patient was depressed) but applied
dimensional instruments to ensure accuracy of diag-
noses [38,39]. All but one study used a cluster allocation
design, randomising all included general practices to
either intervention or control group. Only Llewellyn-
Jones et al. (1999) conducted a serial designed survey,
randomising each consecutive patient to the experimen-
tal groups [40]. Four research groups planned to train
the control group practitioners after the end of the trial
while the other four had them assigned to usual care
groups with no further support provided. However,
three study teams chose to provide the physicians of the
control groups with depression specific guidelines
[36,39,40]. In the Dutch study it is highlighted, that all
practitioners are generally encouraged to adhere to
guideline concordant treatment [33].
Interventions
As for interventional strategies, education and training
of the participating general practitioners was the sole
intervention in three studies [33,38,41]. These studies
did not provide any other organisational support for the
practices. King et al. (2002) pose an exception to the
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Criterion Score and rating criteria
(1) Objectives and specification
main outcomes a priori
0 = objectives unclear
1 = objectives clear but main outcomes not specified a priori
2 = objectives clear with a priori specification of main method
for assessment of outcome
(2) Adequate sample size (n per group) 0 = inadequate (< 50/group)
1 = moderate (50-100/group)
2 = large (> 100/group or justified by power calculations)
(3) Appropriate duration of trial including follow up 0 = too short (< 3 months)
1 = reasonable length (3-6 months)
2 = long enough for assessment of long term outcomes (6-12 months)
(4) Power calculation 0 = not reported
1 = mentioned without details
2 = details of calculations provided
(5) Method of allocation 0 = unrandomized and likely to be biased
1 = partially or quasi randomized with some bias possible
2 = randomized allocation
(6) Concealment of allocation 0 = not done or not reported
2 = concealment of allocation code detailed
(7) Clear description of treatments (including doses of drugs used) and
adjunctive treatments
0 = main treatments not clearly described
1 = inadequate details of main or adjunctive treatments
2 = full details of main and adjunctive treatments
(8) Blinding of subjects 0 = not done
1 = done but no test of blind
2 = done and integrity of blind tested
(9) Source of subjects described and representative sample recruitment 0 = source of subjects not described
1 = source of subjects given but no information on sampling or use
of unrepresentative sample (for example, volunteers)
2 = source of subjects described plus representative sample taken
(for example, all consecutive admissions or referrals, or random
sample taken)
(10) Use of diagnostic criteria (or clear specification of inclusion criteria) 0 = none
1 = diagnostic criteria or clear inclusion criteria
2 = diagnostic criteria plus specification of severity
(11) Record of exclusion criteria and number of exclusions and refusals
reported
0 = criteria and number not reported
1 = criteria or number of exclusions and refusals not reported
2 = criteria and number of exclusions and refusals reported
(12) Description of sample demographics 0 = little/no information (only age/sex)
1 = basic details (for example, marital status/ethnicity)
2 = full description (for example, socioeconomic status,
clinical history)
(13) Blinding of assessor 0 = not done
1 = done but no test of blind
2 = done and integrity of blind tested
(14) Record of number and reasons for withdrawal by group 0 = no info on withdrawals by group
1 = withdrawals by group reported without reason
2 = withdrawals and reason by group
(15) Outcome measures described clearly (and therefore replicable) or use
of validated (or referenced) instruments
0 = main outcomes not described clearly
1 = some of main outcomes not clearly described 2 = main outcomes
clearly described or valid and reliable
instruments used
(16) Information on comparability and adjustment
for differences in analysis
0 = no information on comparability
1 = some information on comparability with appropriate
adjustment
2 = sufficient information on comparability with appropriate
adjustment
(17) Inclusion of all subjects in analyses (Intention to treat analysis) 0 = no
2 = yes
(18) Presentation of results with inclusion of data forre-analysis of main
outcomes (for example, SDs)
0 = little information presented
1 = adequate information
2 = comprehensive
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vide a specific interventional method (brief cognitive
behavioural therapy) [41], while in the remaining trial
physicians were only provided with lectures on
assessment and treatment of depression. Four studies
made use of guideline implementation [35-37,39]. These
studies can be seen as providing a more intense inter-
vention, as practitioners were trained and additionally
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Figure 1 Search Strategy.
Table 1 Quality assessment (Based on Moncrieff et al., 2001) (Continued)
(19) Appropriate statistical analysis (including correction for multiple tests
where applicable)
0 = inadequate
1 = adequate
2 = comprehensive and appropriate
(20) Conclusions justified 0 = no
1 = partially
2 = yes
(21) Declaration of interests (for example, 0 = no
source of funding)
0=n o
2 = yes
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al. (2000) and Worrall et al. (1999) focussed the GP
training on implementing guidelines [37,39]. Thompson
et al. (2000) also educated practitioners but additionally
tried to implement guideline concordant treatment [35].
Baker et al. (2001) used a tailored application of practi-
tioner training by firstly analysing possible obstacles for
successful guidelines implementation and then deliver-
ing individualised help to the GPs [36].
Regarding more complex interventions, it can be con-
cluded that provider education plays the central part in
the programme conducted by Llewellyn-Jones et al.
(1999).
The mean quality score of all studies was at 34.91
points and ranged from 26 to 39 (individual scores in
table 2). Criteria such as random allocation as proposed
by the Cochrane Collaboration Handbook were ade-
quately addressed by all studies [42].
Table 2 Study Characteristics
Study Country Recruitment,
Inclusion Criteria
Randomization N
a Intervention, Role of GP Training Control
Group
Comparison Quality
Baker
(2001) [36]
GB Consecutive patients;
≥ 18 yrs
Patients seeking
consultation for new-
onset depression
Practices 402 Tailored intervention to promote
guideline implementation
(additional feedback, educational
visits, group discussions)
Additional to guideline
UC
b Patients of
experimental group
vs. control group
30
Bosmans
(2006) [33]
NL Consecutive patients;
≥ 55 yrs
PRIME-MD = MD
Practices 145 4 hrs training session on screening,
diagnosis and treatment as in
Dutch guidelines
UC Patients of
experimental group
vs. control group
39
Gask (2004)
[38]
GB GP referral;
16-65 yrs
Intention or current
treatment of
depression
(symptoms < 6 mo)
HAM-D ≥ 13
Practice 189 Acquisition of clinical skills, 5
lectures à 2 hrs on assessment and
treatment;
Sole intervention
WL Patients of
experimental group
vs. control group
36
Kendrick
(2001) [34]
Thompson
(2000) [35]
GB Consecutive patients;
≥ 16 yrs
HADS-D ≥ 8
Practice 733 Guideline implementation & GP
training (4 h seminars, educators
available for 9 more mo);
Additional to guideline
WL Patients of
experimental group
vs. control group
Sensitivity of
recognition rates of
experimental group
vs. control group
36
King (2002)
[41]
GB Consecutive patients;
≥ 18 yrs
HADS-D/A ≥ 11
Practice 272 Training of GPs in brief cognitive
behaviour therapy (4 half day
workshops);
Sole intervention
WL Patients of
experimental group
vs. control group
34
Llewellyn-
Jones
(1999)
[40]
AUS Residential facility;
≥ 65 yrs
GDS ≥ 10
MMSE ≥ 18
Patient 220 Shared Care Intervention, including
GP training & education, health
education and promotion,
psychoeducation;
Central part of complex
intervention
WL
c Experimental group
vs. control group
33
Rost (2001)
[44]
Pyne
(2003) [43]
Rost (2005)
[45]
USA GP referral;
DSM III-R MD (latter
two studies exclude
patients currently in
treatment)
Practice 479 QuEST intervention, 4 academic
telephone calls to implement
guidelines, nurse w/8-hour face-to-
face training;
Guidelines implementation
UC Patients of
experimental group
vs. control group
d
38
Worrall
(1999) [39]
CAN GP referral;
GP diagnosis and
severity rating, later
CES-D ≥ 16
Practice 147 3-hour sessions on guideline
implementation + possible
consultation of psychiatrist;
Guidelines implementation
UC
b Patients of
experimental group
vs. control group
26
a At baseline;
b Receipt of guidelines by mail;
c Assessment of control group during first period of study, followed by intervention and assessment of experimental
group;
d Rost et al. (2001): comparison recently treated patients vs. patients beginning new treatment episode, analysis for both intervention groups.
Abbreviations: CES-D - Center for Epidemiologic Studies Depression Scale; CIDI - Composite International Diagnostic Interview; GDS - Geriatric Depression Scale;
GP - General Practitioner; HADS-D/A - Hospital Anxiety and Depression Scale; HAM-D - Hamilton Depression Scale; MD - Major Depression; MMSE - Mini Mental
Status Examination; mo - month(s); PRIME-MD - Primary care Evaluation of Mental Disorders; QI - Quality Improvement; UC - Usual Care; w/- with; WL - Waiting
List; yrs - years.
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Table 3 summarises all study results. The three studies
solely providing physician education found no change in
symptom severity. Neither lectures for more qualified
assessment and treatment [33,38], nor training in brief
cognitive behavioural therapy [41] led to significant
symptom change in patients of trained physicians. Intro-
ducing additional guidelines and using them during
practitioner training, two studies showed a mid and
long term significant change in symptom load
[39,43-45]. Both trials report small effect sizes (d = 0.22-
0.29). Short term, one study was able to show an
increases probability of reducing the depression score
below a clinically relevant cut-point [36]. Yet, another
study fails to show effects of the intervention introdu-
cing guidelines. Not only was there no effect of the
practitioner training on diagnosis sensitivity and specifi-
city, patient also do not profit symptom wise or regard-
ing hospital admittance [34,35].
As for the more complex interventional strategies,
there is one study in which general practitioner and pro-
vider training plays a central role [40]. In a sample of
Table 3 Study Results
Study Follow
Up
Attrition
Rate %
a
Outcome Results Limitations Effect
Size
b
Baker
(2001) [36]
16
weeks
6 Proportion of
patients w/
BDI < 11
Sign. diff in proportion of patients w/BDI >
11 (OR = 2.5)
Tailored intervention that makes GP
comparison impossible since they all
received diff kinds of intervention
/
Bosmans
(2006) [33]
12 mo 21 PRIME-MD No sign. diff in MD recovery Possible Hawthorne effect, less severe
episodes of MD in primary care, no
blinding of patients
-0.07
Gask (2004)
[38]
3, 12
mo
37 HAM-D No sign. diff in scores at both follow up
points
Use of a new-onset (depressed less than 6
mo) sample
Attrition rate rather high
-0.24
Kendrick
(2001) [34]
12 mo 19 Hospital
Admittance
No sign. difference Implemented guidelines had been tested
in highly selected samples
Dimensional diagnosis
Potential conservative bias (chronic
depressed patients)
/
Thompson
(2000) [35]
6
weeks/
6m o
50 HAD No diff in improvement, no diff in caseness
rating at both points
Only patients recognized as cases at
baseline improve sign. during first 6 weeks
(p = 0.044), no diff at 6 mo
See Kendrick (2001) /
Diagnosis
sensitivity
No diff in sensitivity nor specificity See Kendrick (2001) /
King (2002)
[41]
6 mo 10 BDI No sign. diff in BDI scores (p = 0.84) Smaller sample than anticipated
Cut off score for inclusion rather high
(makes intervention effect of CBT by lay
GPs less likely)
0.08
Llewellyn-
Jones
(1999)
[40]
9.5 mo 23 GDS Sign. change in GDS scores Serial mono-centered design
Control group assessment before
implementation of intervention
-0.17
Rost (2001)
[44]
6 mo 10 mCES-D Sign. reduction in score in patients
beginning new treatment episode
GP training effect unclear, feedback of
diagnosis could be responsible for
treatment effect
Homogenous sample
-0.29
Pyne
(2003) [43]
12 mo 65 Depression
severity
Sign. decrease (7.7 units) in experimental
group
See Rost (2001) /
Rost (2005)
[45]
24 mo 70 Depression
Free Days
Sign. more depression free days in
experimental group (647.6 vs. 558.2)
See Rost (2001) /
Worrall
(1999) [39]
6 mo ? Gain score
CES-D
Sign. improvement in experimental group Possible Hawthorne effect -0.22
a all groups, last follow up;
b calculated as the mean difference of experimental and control group at the latest post-treatment measurement;
c adopted from
Bower et al. (2006) [45].
Abbreviations: BDI - Beck’s Depression Inventory; CBT - Cognitive Behavioral Therapy; CE Ratio - Cost Effectiveness Ratio; mCES-D - (modified) Center for
Epidemiologic Studies Depression Scale; CIDI - Composite International Diagnostic Interview; diff - difference; GDS - Geriatric Depression Scale; GP - General
Practitioner; HAD - Hospital Anxiety and Depression Scale; HAM-D Hamilton Depression Scale; mo - month(s); MD - Major Depression; PRIME-MD - Primary care
Evaluation of Mental Disorders; QALY - Quality of Adjusted Life Year; SF12 - Short Form 12-Item Health Survey; sign - significant
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Jones and colleagues (1999) show a significant change in
symptom quantity associated with a small effect size of
Cohen’s d = 0.17.
In studies that provided guidelines for the non-trained
control group practitioners [36,39,40], additional train-
ing and interventions in the experimental groups led to
positive outcome changes (see tables 2 and 3).
Meta-analysis
The forest-plot of the conducted meta-analysis can be
found in Figure 2. Three studies with only provider
training provided data for meta-analysis. They found a
non-significant decrease in depressive symptom load
(pooled effect size d=-0.07, 95% CI -0.24 to 0.10, I
2 =
21%).
Two studies were categorized as implementing addi-
tional guidelines to primary care. They showed the high-
est pooled effect sizes and a significant decrease in
depressive symptoms in the intervention groups (d=-
0.26, 95% CI -0.48 to -0.04). The overall effect size,
including a study with a more complex intervention was
determined at d=-0.15 (95% CI -0.27 to -0.03]), favour-
ing the experimental groups.
Discussion
It is apparent that there are only few trials evaluating
the effect of primary care physician education on health
outcomes of patients. Especially during the last six years
no results of education based interventions have been
published. It seems that the research focus has shifted
to more complex interventions encompassing collabora-
tive and stepped care approaches by introducing mental
health specialists to the primary care setting [46-48].
Regarding the results of the reviewed studies, this
approach seems more than justified - it has yet to be
shown that training practitioners alone yields significant
symptom changes; however, this conclusion is only
based on three relevant studies that themselves are
highly diverse. While the study by Gask et al. (2004)
struggles with high attrition rates, King et al. (2002)
used a rather high cut-off and included chronically
depressed patients, possibly leading to a conservative
bias and therefore underestimating the treatment effect
[38,41]. The authors argue that the applied kind of brief
cognitive behavioural therapy might have been treat-
ment approach not sufficiently intense for highly
depressed patients. Bosmans et al. (2006) find that
including less severely affected patients might have led
to an underestimation of the efficacy of anti-depressant
treatment [33].
Sample selection plays a major role in assessing treat-
ment effects in general. One could assume that severely
affected patients benefit more from treatment in clinical
studies (as they can show a higher reduction in quantity
of symptoms). In line with this, a categorical diagnostic
approach for patient inclusion by applying diagnostic
categories as provided by the Diagnostic and Statistical
Manual of Mental Disorders (DSM) might lead to a
sample of more severely affected patients [33,36,37].
Figure 2 Forest-Plot.
Sikorski et al. BMC Health Services Research 2012, 12:10
http://www.biomedcentral.com/1472-6963/12/10
Page 8 of 11Furthermore, the kind of treatment has an effect. In
the context of stepped care, this issue is addressed by
providing more-intense treatment options to higher
affected patients [25].
Both argumentations can provide explanations for the
positive results found by studies implementing additional
guideline usage by general practitioners. Small effect
sizes were shown by those studies including patients with
new-onset depression, rather than chronically depressed
patients (as done by Kendrick et al., 2001 not resulting in
positive symptom change). Obviously, the effect of mere
attention to the trained practitioners as well as to the
patients themselves (referred to as Hawthorne effect) has
to be considered a possible moderating variable in study
designs. This would lead to better outcomes and perfor-
mances of the control groups even though they received
no active intervention; thus, the differences found may
possibly be even higher.
The justification for more complex interventions to
improve primary care depression treatment is replicated in
the analysis of included studies and basically goes in line
with a previous review [21], however, we did find more
evidence in newer studies that support guideline imple-
mentation to be effective in symptom reduction. One trial
applying more complex strategies both yielded significant
changes in symptom outcomes; however, it remains
unclear how much of the effect can be attributed to the
physicians’ education. Bower et al. (2006) conducted a
meta-regression to evaluate active ingredients of collabora-
tive care interventions [49]. In this analysis, primary care
physician training is not associated with a positive change
in depressive symptoms nor with a change in antidepres-
sant use even in univariate calculations. Rather than provi-
der education, systematic identification of patients,
professional background of staff and supervision proved to
be significant predictors of symptom change. It becomes
clear that researchers should not assume an additive effect
of treatment modules; especially in view of economic con-
siderations, collaborative care cannot mean implementing
as many treatment options as possible. This analysis of
one specific potentially effective part of collaborative care
is leading the way to a more thorough understanding of
complex interventions and has to be pursued without
neglecting the fact that more simple interventions can also
lead to significant changes in patient outcomes as shown
in this review.
However, it may not be appropriate to solely focus on
outcomes of symptomatology as enhanced primary care
supply may not be directly associated with such. Even
the included studies show a rise in adherence to medi-
cation treatment [39] and medication treatment in gen-
eral [34,44,50]. It has been shown that effectiveness of
antidepressant treatment increases with depression
severity [51]; an effect of increased antidepressant treat-
ment in a sample of mildly depressed patients will
therefore be small [as seen in the studies by [33,39]].
Strengths and Limitations
This review only included randomised controlled trials,
and therefore neglected observational and non-rando-
mised studies. RCTs often adhere to strict exclusion cri-
teria, thus making generalisability to primary care patients
difficult. This also applies to the current review since stu-
dies with specialised co-morbid patient groups were
excluded; however, regarding the heterogeneity of primary
care patients, an adequate representation of studies seems
hard to achieve in any case. The reported studies differ
substantially in content, duration, intensity and frequency
of the intervention programmes, making comparisons dif-
ficult. However, we were able to conduct a meta-analysis,
quantifying the results of the studies. Meta-regression that
could help determine the influence of these factors was
not applicable due to the limited number of studies.
This partly results from the relatively narrow search
strategy; only when education or training efforts of GPs
were mentioned within title and abstract, the article was
found with the applied search strategy. Earlier publica-
tions (before 1999) were not searched. Gilbody et al.
mention one previous trial that showed positive effects
of provider training but equally emphasise methodologi-
cal weakness of this trial [21,52], so we did include rele-
vant trials that live up to methodological requirements.”.
Furthermore, a possible publication bias cannot be
ruled out or determined with a qualitative review as
this, especially under the regard of not searching grey
literature. Regarding the fact that almost only studies
from anglophone countries were found might be an
indicator for unpublished studies with negative out-
comes from other countries.
Conclusions
It seems that provider training, if combined with guide-
line implementation, contributes to enhanced care for
depression in primary care even associated with possible
positive symptom changes. Providing a guideline and
training practitioners to adhere to guideline-concordant
treatment might be a measure of intervention that
endures even after the intervention ends.
Additional material
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